A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations
Alvin F Wells,1,2 Nicole Jodat,1 Michael Schiff3 1Rheumatology and Immunotherapy Center, Franklin, WI, USA; 2Duke University Medical Center, Durham, NC, USA; 3University of Colorado, School of Medicine, Denver, CO, USA Abstract: There are now more therapeutic options for the treatment of rheumato...
Main Authors: | Wells AF, Jodat N, Schiff M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-02-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/a-critical-evaluation-of-the-role-of-subcutaneous-abatacept-in-the-tre-a15833 |
Similar Items
-
Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
by: R. Ariza, et al.
Published: (2014-07-01) -
Subcutaneous abatacept in rheumatoid arthritis: A real-life experience
by: Juan Camilo Sarmiento-Monroy, et al.
Published: (2019-12-01) -
Comparative clinical utility of once-weekly subcutaneous abatacept in the management of rheumatoid arthritis
by: Rakieh C, et al.
Published: (2014-04-01) -
Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
by: Augustine JM, et al.
Published: (2012-02-01) -
Experience with abatacept used in the treatment of patients with rheumatoid arthritis
by: V I Mazurov, et al.
Published: (2011-12-01)